Search Results

Pim3 up-regulation by YY1 contributes to diabetes-induced cardiac hypertrophy and heart failure.

• Authors : Xiao-Ping Jin¹; Yi-Fei Ren¹; Li-Guo Wang¹

• Source: Iranian Journal of Basic Medical Sciences. Feb2025, Vol. 28 Issue 2, p245-253. 9p.

Record details

Syringaldehyde Alleviates Cardiac Hypertrophy Induced by Hyperglycemia in H9c2 Cells Through GLP-1 Receptor Signals.

• Authors : Li, Yingxiao¹ (AUTHOR) ; Hsu, Chao-Tien² (AUTHOR) ; Yang, Ting-Ting³ (AUTHOR)

• Source: Pharmaceuticals (14248247). Jan2025, Vol. 18 Issue 1, p110. 16p.

Record details

SIRT5 prevents mitochondrial dysfunction and cardiac hypertrophy induced by RIP140.

• Authors : Liying Liang¹; Yi Huang²; Qiujuan Wang¹

• Source: Iranian Journal of Basic Medical Sciences. Apr2025, Vol. 28 Issue 4, p477-485. 9p.

Record details

Pathophysiology of Angiotensin II-Mediated Hypertension, Cardiac Hypertrophy, and Failure: A Perspective from Macrophages.

• Authors : Carter, Kelly¹ (AUTHOR); Shah, Eshan¹ (AUTHOR); Waite, Jessica¹ (AUTHOR)

• Source: Cells (2073-4409). Dec2024, Vol. 13 Issue 23, p2001. 28p.

Record details

TongGuanWan Alleviates Doxorubicin- and Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis by Modulating Apoptotic and Fibrotic Pathways.

• Authors : Yoon, Jung-Joo¹ (AUTHOR) ; Tai, Ai-Lin^1,2 (AUTHOR) ; Kim, Hye-Yoom¹ (AUTHOR)

Subjects: *CARDIAC hypertrophy; *HEART fibrosis; *WESTERN immunoblotting

• Source: International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 19, p10573. 19p.

Record details

Upregulated LIMD1 alleviates pressure overload-induced cardiac hypertrophy via inhibits YAP1/AKT/GSK3β signaling.

• Authors : Xie, Fengwen¹ (AUTHOR); Yuan, Bin² (AUTHOR); Zhang, Ye¹ (AUTHOR)

Subjects: *CELLULAR signal transduction; *CARDIAC hypertrophy; *HEART diseases

• Source: PLoS ONE. 2/12/2025, Vol. 20 Issue 2, p1-11. 11p.

Record details

RACK1 contributes to the upregulation of embryonic genes in a model of cardiac hypertrophy.

• Authors : Ceci, Marcello¹ (AUTHOR); Bonvissuto, Davide² (AUTHOR); Papetti, Flavia¹ (AUTHOR)

• Source: Scientific Reports. 10/30/2024, Vol. 14 Issue 1, p1-17. 17p.

Record details

TMEM100 acts as a TAK1 receptor that prevents pathological cardiac hypertrophy progression.

• Authors : Zhang, Bin-Bin¹ (AUTHOR); Zhao, Yi-Lin² (AUTHOR); Lu, Yan-Yu¹ (AUTHOR)

• Source: Cell Communication & Signaling. 9/11/2024, Vol. 22 Issue 1, p1-16. 16p.

Record details

The m7G Methyltransferase Mettl1 Drives Cardiac Hypertrophy by Regulating SRSF9‐Mediated Splicing of NFATc4.

• Authors : Yu, Shuting¹ (AUTHOR); Sun, ZhiYong¹ (AUTHOR); Ju, Tiantian¹ (AUTHOR)

• Source: Advanced Science. 8/7/2024, Vol. 11 Issue 29, p1-18. 18p.

Record details

Mitochondria and NLRP3 inflammasome in cardiac hypertrophy.

• Authors : Yan, Ruyu^1,2 (AUTHOR); Sun, Yuxin³ (AUTHOR); Yang, Yifan¹ (AUTHOR)

Subjects: *CARDIAC hypertrophy; *NLRP3 protein; *INFLAMMASOMES

• Source: Molecular & Cellular Biochemistry. Jul2024, Vol. 479 Issue 7, p1571-1582. 12p.

Record details